4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001209191-21-029351
EVP, Chief of Clinical Affairs sold 3,223 shares at $40.29 ($129,853)
- EVP, Chief of Clinical Affairs acquired 3,223 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morosini Deborah EVP, Chief of Clinical Affairs | 2021-04-29 | Option exercise | +3,223 | $1.89 | $6,091 | 3,667 | D |
| Morosini Deborah EVP, Chief of Clinical Affairs | 2021-04-29 | Sale | −3,223 | $40.29 | $129,853 | 444 | D |
| Derivatives | |||||||
| Morosini Deborah EVP, Chief of Clinical Affairs | 2021-04-29 | Option exercise · Employee Stock Option (right to buy) | −3,223 | 4,323 | D | ||
| Open-market sales · 3,223 sh · avg $40.29 · $129,853 | |||||||
Loading xslF345X03/doc4.xml…